Total Visits

Views
The data record for the primary endpoint analysis: The adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency)380

Total Visits Per Month

September 2020October 2020November 2020December 2020January 2021February 2021March 2021
The data record for the primary endpoint analysis: The adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency)411935174

File Downloads

Views
Illustrative Data Transfer Agreement.docx160

Top country views

Views
United States100
United Kingdom64
France36
China27
Germany20
India18
Switzerland9
Canada8
Russia4
Bulgaria3

Top cities views

Views
Ashburn48
Cambridge27
Beijing19
Boardman7
Fairfield6
Basel5
Oakland5
Hangzhou4
Oxford4
Fremont3